Wilmington, DE · Founded 2017 · Privately Held (backing)
Developer of a pharmacological platform designed to treat obesity and its related chronic diseases through targeted small-molecule therapies. Eolo Pharma is based in Wilmington, DE and was founded in 2017. Its last reported valuation was $18 million in Sep 2022. It has raised $7.7 million.
Last reported valuation
$18.0M
Oct 2026
Priced at
—
Total raised
$7.7M
Last round
—
Team — not yet on record
No current team members for Eolo Pharma are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Eolo Pharma with a free account
·Watch Eolo Pharma: the Monday email on marks, rounds and moves
